Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jiawen Qian"'
Autor:
Lin Chen, Gongbiao Lin, Jiawen Qian, Zhihong Chen, Xiaobo Wu, Jing Lin, Ying Chen, Qing Chen, Zhaocheng Zhuang, Yihong Hong, Jing Wang, Fengqiong Liu, Baochang He, Fa Chen
Publikováno v:
Head & Neck. 43:2148-2158
BACKGROUND Although nonsurgical treatment strategy is increasingly adopted in patients with locoregionally advanced laryngeal squamous cell carcinoma (LSCC), survival disparities were reported between surgical treatment modality and organ preservatio
Autor:
Xiaodan Bao, Lihong Wei, Jing Wang, Bin Shi, Lingjun Yan, Fengqiong Liu, Jiawen Qian, Baochang He, Yihong Hong, Fa Chen, Lizhen Pan, Lisong Lin, Jing Lin, Zhaocheng Zhuang, Xiaoyan Zheng, Qing Chen, Lin Chen, Yu Qiu
Publikováno v:
Head & Neck. 42:3263-3274
Background The aim of the study was to elucidate the relationship between systemic inflammation response index (SIRI) and the prognosis of postoperative oral squamous cell carcinoma (OSCC) patients. Methods The prognostic value of SIRI was evaluated
Autor:
Junying Xu, Jiawen Qian, Feifei Luo, Jiao Yang, Ronghua Liu, Chujun Zhao, Yuedi Wang, Yiwei Chu, Bo Wang, Chen Wang
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-13 (2018)
Journal of Neuroinflammation
Journal of Neuroinflammation
Background PD-L1 is an immune inhibitory receptor ligand that leads to T cell dysfunction and apoptosis by binding to its receptor PD-1, which works in braking inflammatory response and conspiring tumor immune evasion. However, in gliomas, the cause
Autor:
Yiwei Chu, Enyu Huang, Zhou Lu, Jiawen Qian, Ronghua Liu, Jiajing Liu, Jiao Yang, Dan Zhang, Xiaoming Liu
Publikováno v:
Hepatology. 67:1027-1040
Interleukin-22 (IL-22), as a link between leukocytic and nonleukocytic cells, has gained increasing attention for its pronounced tissue-protective properties. MicroRNAs, emerging as crucial immune modulators, have been reported to be involved in the
Autor:
Yuting Deng, Yiwei Chu, Jiao Yang, Yuedi Wang, Ronghua Liu, Zhou Lu, Feifei Luo, Jiawen Qian, Dan Zhang
Publikováno v:
International Journal of Cancer. 141:2082-2092
MiR-15a/16, a miRNA cluster located at chromosome 13q14, has been reported to act as an immune regulator in inflammatory disorders besides its aberrant expression in cancers. However, little is known about its regulation in tumor-infiltrating immune
Publikováno v:
Cell Research. 26:850-853
Bifunctional αHER2/CD3 RNA-engineered CART-like human T cells specifically eliminate HER2 + gastric cancer
Autor:
Yiwei Chu, Jiawen Qian, Yanqing Wang, Jun Liu, Lumin Zhang, Hiromi Kubagawa, Ji-Yang Wang, Takeshi Tsubata, Ermeng Xiong, Hanying Zhu
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology, Vol 9 (2018)
The marginal zone B cells (MZB) are located at the interface between the circulation and lymphoid tissue and as a gatekeeper play important roles in both innate and adaptive immune responses. We have previously found that MZB are significantly reduce
Autor:
Jiao Yang, Luman Wang, Zhou Lu, Chen Wang, Yuting Deng, Yiwei Chu, Jun Liu, Mingfang Lu, Jiawen Qian, Ronghua Liu, Yuedi Wang, Feifei Luo, Ji-Yang Wang
Publikováno v:
Cancer immunology research. 6(10)
Gliomas, the most common primary neoplasms in the brain, are notorious for their ability to evade the immune response. Despite microglial infiltration in gliomas, expression of MHC class II molecules in those microglia is compromised. Here, we report
Autor:
Guangwei Liu, Enyu Huang, Hongguang Zhu, Luman Wang, Feifei Luo, Ronghua Liu, Jiao Yang, Jiajing Liu, Yuting Deng, Dan Zhang, Zhanju Liu, Jiawen Qian, Jing Qian, Jie Gu, Zhiming Wang, Yiwei Chu, Hushan Zhang, Xuechao Jiang, Zhou Lu, Youcun Qian, Xiaoming Liu
Publikováno v:
Gastroenterology. 154(3)
Background & Aims B cells infiltrate tumors, but little is known about how they affect tumor growth and progression. microRNA15A (MIR15A or miRNA15A) and microRNA16-1 (MIR16-1 or miRNA16-1) regulate cell proliferation, apoptosis, and drug resistance.
Autor:
Yiwei Chu, Xiaoming Liu, Yuting Deng, Luman Wang, Jiawen Qian, Ronghua Liu, Feifei Luo, Zhou Lu, Jiao Yang, Enyu Huang, Dan Zhang, Xuechao Jiang
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9789401775533
Biological response modifiers (BRMs) emerge as a lay of new compounds or approaches used in improving cancer immunotherapy. Evidences highlight that cytokines, Toll-like receptor (TLR) signaling, and noncoding RNAs are of crucial roles in modulating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::171485228164a65775d8aba289f91cc4
https://doi.org/10.1007/978-94-017-7555-7_2
https://doi.org/10.1007/978-94-017-7555-7_2